Cell Source, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cell Source, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $17.80K.
- Cell Source, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $571.80K.
- Cell Source, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $19.90K.
- Cell Source, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $603.35K, a 503.35% increase year-over-year.
- Cell Source, Inc. stock issued during period, value, new issues for fiscal 2024 was $914.40K, a 140.00% increase from fiscal 2023.
- Cell Source, Inc. stock issued during period, value, new issues for fiscal 2023 was $381.00K.
- Cell Source, Inc. stock issued during period, value, new issues for fiscal 2020 was $728.35K.
- Cell Source, Inc. stock issued during period, value, new issues for fiscal 2018 was $2.24M, a 0.00% change from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $914.40K 10-K · filed 2026-04-07 | |
| 2024-09-30 | $17.80K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $571.80K 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $19.90K 10-Q · filed 2026-05-14 | |
| 2023-12-31 | $381.00K 10-K · filed 2024-06-24 | |
| 2020-12-31 | $728.35K 10-K · filed 2022-04-15 | |
| 2020-09-30 | $603.35K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $25.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $100.00K 10-Q · filed 2021-11-15 | |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-13 | $3.41M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $798.27K 10-Q · filed 2020-11-13 | $3.31M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-03-31 | $325.00K 10-Q · filed 2020-11-13 | $2.52M derived: sum of 4 quarters · filed 2020-11-13 |
| 2018-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $2.24M 10-K · filed 2019-04-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-18 | |
| 2018-03-31 | $50.00K 10-Q · filed 2019-05-20 | |
| 2017-12-31 | $2.24M 10-K · filed 2019-04-01 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $3.01M 10-K · filed 2016-04-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | |
| 2013-12-31 | $551.50K 10-K · filed 2015-03-13 |